Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
US-10517843-B2 · Dec 31, 2019 · US
This page is not indexed by search engines while we improve data quality.
Io Therapeutics Inc patents in 2019
Io Therapeutics Inc was listed as an assignee on 34 patent publications in 2019.
| Metric | Value |
|---|---|
| Company | Io Therapeutics Inc |
| Year | 2019 |
| Patents | 34 |
Patents
Representative publications for Io Therapeutics Inc in 2019.
Treatment of autoimmune diseases with combinations of rxr agonists and thyroid hormones
US-2019381022-A1 · Dec 19, 2019 · US
Treatment of cancer with combinations of rxr agonists and thyroid hormones
US-2019365681-A1 · Dec 5, 2019 · US
Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones
US-10485778-B2 · Nov 26, 2019 · US
Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy
US-10485775-B2 · Nov 26, 2019 · US
Top CPC classifications
Most common classification codes for Io Therapeutics Inc in 2019.
| CPC | Patents |
|---|---|
| A61K45/06 | 30 |
| A61K31/192 | 29 |
| A61K2300/00 | 19 |
| A61P35/00 | 18 |
| A61K31/198 | 15 |
Related pages
Navigate to parent entity pages.